logo
logo

Spine Thera, Inc. announced it raised $1.22 Million in an initial filing from an offering of $4 Million

Dec 10, 2021•over 3 years ago

Amount Raised

$1.22 Million

Round Type

seed

PlymouthPharmaceuticalBiotechnology

Company Information

Company

SpineThera, Inc.

Location

15600 MEDINA ROAD

Plymouth, Minnesota, United States

About

SpineThera, Inc. is a privately held, clinical-stage pharmaceutical company focused on the development of SX600, a novel formulation of extended-release dexamethasone microspheres for epidural injection for the management of lumbar radicular pain. They are also known for their patented micro-suspension platform technology, providing sustained release of the active pharmaceutical ingredient with superior injectability at ultra-high concentrations.